Table 2.
Adverse events (AEs) in RESIST and RESIST 2 trials
| Adverse events | TPV/r + OBR (n = 746) |
CPI/r + OBR (n = 737) [%] |
|---|---|---|
| Gastrointestinal Disorders | 46.8 | 42.6 |
| Diarrhoea | 13.4 | 11.1 |
| Nausea | 11.7 | 7.9 |
| Vomiting | 3.8 | 2.8 |
| Flatulence | 2.9 | 1.9 |
| Abdominal disentsion | 2.5 | 1.8 |
| Abdominal pain | 2.4 | 2.7 |
| Loose stools | 1.6 | 1.2 |
| Dyspepsia | 1.1 | 0.7 |
| Metabolism and Nutrition Disorders | ||
| Anorexia | 1.1 | 0.9 |
| Hypertriglyeridaemia | 1.9 | 0.8 |
| Hyperlipidaemia | 1.2 | 0.4 |
| General Disorders | ||
| Fatigue | 4.4 | 2.6 |
| Nervous System Disorders | ||
| Headache | 3.5 | 1.2 |
| Skin Disorders | ||
| Rash | 1.6 | 0.9 |
| Puritus | 1.1 | 0.4 |